Multiple drugsMucormycosis following off-label use, elevated serum creatinine and hypokalaemia: 6 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1889卷 / 1期

关键词：

D O I：

10.1007/s40278-022-08906-1

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：227 / 228

页数：1

相关论文

共 50 条

[31] ClozapineAgranulocytosis following off-label use: 2 case reports
Reactions Weekly, 2022, 1924 (1) : 164 - 164
[32] FerumoxytolNausea following off-label use: 2 case reports
Reactions Weekly, 2017, 1650 (1) : 142 - 142
[33] BebtelovimabAnaphylaxis following off-label use: 2 case reports
Reactions Weekly, 2023, 1954 (1) : 113 - 113
[34] SpironolactoneHyperkalaemia following off-label use: 3 case reports
Reactions Weekly, 2023, 1949 (1) : 385 - 385
[35] ImiquimodLymphoedema following off-label use: 3 case reports
Reactions Weekly, 2018, 1711 (1) : 146 - 146
[36] UstekinumabMyositis following off-label use: 2 case reports
Reactions Weekly, 2021, 1870 (1) : 306 - 306
[37] HydroxychloroquineHypoglycaemia following off-label use: 3 case reports
Reactions Weekly, 2020, 1822 (1) : 152 - 152
[38] MogamulizumabRash following off-label use: 4 case reports
Reactions Weekly, 2023, 1984 (1) : 345 - 345
[39] BevacizumabEndophthalmitis following off-label use: 2 case reports
Reactions Weekly, 2019, 1757 (1) : 64 - 64
[40] SarilumabNeutropenia following off-label use: 2 case reports
Reactions Weekly, 2022, 1921 (1) : 255 - 255

← 1 2 3 4 5 →